INFUSYSTEM HOLDINGS INC (INFU)
Health Care · Durable medical equipment services and home infusion therapy · NYSE American
InfuSystem is a specialized provider of durable medical equipment and managed healthcare services that enables the seamless transition of oncology and other infusion therapies from clinical settings to the home.
What INFUSYSTEM HOLDINGS INC does
InfuSystem Holdings is a national healthcare service provider operating a two-platform model: Patient Services, which supplies electronic ambulatory infusion pumps and disposable supplies for outpatient oncology and other therapies administered in home and clinical settings, and Device Solutions, which offers equipment rental, sales, consumables, and biomedical support services. The company manages the complete patient care journey—from equipment and consumables provision to 24/7 nursing support, third-party payer billing and revenue cycle management, and biomedical maintenance services. Operating from seven locations in the U.S. and Canada, it serves hospitals, oncology practices, ambulatory surgery centers, and other alternate-site healthcare providers.
Themes: Durable medical equipment (DME) services, Oncology care delivery, Outpatient infusion therapy, Home healthcare / clinic-to-home solutions, Healthcare logistics and supply chain, Healthcare provider outsourcing
Fundamentals
- Price$12.21 as of 2026-08-21 close
- Market cap$243M as of 2026-08-21
- 1-year return+27.1% 2025-08-21 close $9.61 → 2026-08-21 close $12.21
- P/E29.10 as of 2026-08-24
- Net margin+6.0% as of 2026-08-24
- Gross margin+57.5% as of 2026-08-24
- ROE+14.8% as of 2026-08-24
- Debt / equity0.35 as of 2026-08-24
- Revenue growth (YoY)+2.5% as of 2026-08-24
- Revenue CAGR (3y)+9.3% SEC XBRL
- Beta1.52 as of 2026-08-24
- Last reported earnings2026-08-04 SEC EDGAR Form 8-K (Item 2.02)
How INFU compares in its sector
- price-to-earnings ratiomiddle range 203 covered Health Care peers, as of 2026-08-24
- net profit marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- operating marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- gross marginmiddle range 384 covered Health Care peers, as of 2026-08-24
- return on equitytop 25% 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 493 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How INFUSYSTEM HOLDINGS INC looks technically
INFUSYSTEM HOLDINGS INC (INFU) is trading 29.4% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 18 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 36, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 64, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 1 trading day ago (its momentum flipped negative). It made a new 20-day high about 11 trading days ago.
Trend
9
| Distance from the 200-day | it is trading 29.4% above its 200-day average, the long-term trend line — a longer-term uptrend | +29.4% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $10.15 | $10.15 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $9.44 | $9.44 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing high 16 calendar days ago — the swings before that are what the structure reading is measured on | 16 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that upward direction; the labelling fails if price closes below 10.32. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a completed three-part correction. | possible upward five-wave sequence, in wave 4 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 18 trading days ago — a "golden cross", a bullish long-term signal | 18 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 29.4% above | +29.4% |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 36, with buyers in control | 35.7 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 64, neither overbought (above 70) nor oversold (below 30) | 64.3 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($9.89 to $12.93) — its "stochastic" reading is 76 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 76.3 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 1 trading day ago (its momentum flipped negative) | 1 session |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $12.93 | $12.93 |
|---|---|---|
| From the 52-week high | it is 5.6% below its 52-week high (its highest price of the past year) | -5.6% |
| Above the 52-week low | it is 67.5% above its 52-week low (its lowest price of the past year) | +67.5% |
| Below the 52-week high | it is 5.6% below its highest point of the past year | 5.6% |
| Since a 20-day breakout | it made a new 20-day high about 11 trading days ago | 11 sessions |
| Since a 55-day breakout | it made a new 55-day high about 11 trading days ago | 11 sessions |
| All-time high | its highest closing price on record is $23.26 (set on 2021-03-17) | $23.26 |
| Given back of the 52-week move | over the past year its closes ranged ($7.42 to $12.49), and it has given back only a small part of its rise from last year’s low — 6% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $9.19 to $9.36. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 5.5% |
| From the all-time high | it is 47.5% below its all-time high | -47.5% |
| Nearest price level | it is trading 10.2% above a support level at $10.97 — a price it turned at four times since 2025-08-29, most recently on 2026-04-27. Since 2024-08-21 it has 15 such levels below the current price and 0 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -10.2% |
| All-time low | its lowest closing price on record is $0.75 (set on 2011-09-26) | $0.75 |
| Above the all-time low | it is 1528.0% above its all-time low | +1,528% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 91% of the past ~6 months) | 91st percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.5182 between its high and its low — about 4.2% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.5182 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $8.79 and $14.01 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $8.79 – $11.40 – $14.01 |
| Typical daily range (% of price) | its price moves about 4.2% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 4.2% |
| Stretch from the 200-day average | it is trading 5.4 daily ranges above its 200-day average price (29.4% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 5.4 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.65× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
2
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|---|---|
| Since a bearish engulfing | 2 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 2 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.4% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.4% |
|---|---|---|
| Open gap | it gapped 10.0% above the previous close 13 sessions ago and has not traded back through the level it left behind at 9.22 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +10.0% |
| Gap filled | a 2.0% gap down opened on 2026-08-05 has been "filled" 12 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 12 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 2 sessions in a row, a +0.16% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 2 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 31.1 percentage points (the stock gained 33.4% while the market gained 2.3%) | +31.1% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 19.7 percentage points (the stock gained 22.8% while the market gained 3.1%) | +19.7% |
| vs market, 6 months | over the past 6 months this stock beat the market by 42.5 percentage points (the stock gained 53.6% while the market gained 11.1%) | +42.5% |
| vs market, 12 months | over the past 12 months this stock beat the market by 6.6 percentage points (the stock gained 27.1% while the market gained 20.5%) | +6.6% |
Signal agreement
2
| Bullish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: MACD momentum is negative — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 28% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is thin, spanning 1.3% of the share price, which is taken to mean a barrier that gives way easily. | +28.1% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 29% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $9.44 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | +29.3% |
|---|---|---|
| Vs the average paid since it last reported | the price is sitting right on the average price paid since it last reported on 2026-08-04 (its 10-Q), so the typical buyer over that stretch is roughly break-even. That average is $12.24 — a volume-weighted average of daily closes over 14 sessions, not a true tick-by-tick VWAP. | -0.3% |
Price levels it has turned at before
INFU last closed at $12.21 on 2026-08-21. Since 2024-08-21 it has turned at 15 prices below its last close and 0 above; the 3 nearest below are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $10.97 | Support | 10.2% below the last close | turned there four times · 2025-08-29 to 2026-04-27 |
| $10.67 | Support | 12.6% below the last close | turned there three times · 2025-09-23 to 2026-05-06 |
| $10.28 | Support | 15.8% below the last close | turned there twice · 2026-05-22 to 2026-06-29 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes below $10.32.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $10.81 and $11.93 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a completed three-part correction, which fails on a close above $12.93.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Recent golden cross (50-day crossed above 200-day) · Tested and reclaimed 200-day support · MACD just crossed bearish (12/26/9) · in a strong, established uptrend (ADX) · beating the market | Learn: moving average · golden cross · adx · rsi · macd · breakout
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$17.63 range $15.00 – $20.00; median $17.75
Analyst estimates, as of 2026-08-21. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Key risks (from latest filing)
["Reimbursement rate and coverage changes by third-party payers, which could impact demand and pricing for core infusion services (87% of Patient Services revenue from oncology in 2025)","Regulatory and compliance risk related to medical equipment distribution, billing, and nursing services across multiple jurisdictions","Competitive pressure from established DME providers and integrated health systems seeking to bring services in-house, combined with barriers to expansion beyond oncology into other disease states"]
What changed in the latest 10-Q
AI-assisted comparison of INFU's 10-Q filed 2026-05-08 against the prior one filed 2025-11-04.
Management's Discussion & Analysis (MD&A)
- Added:
- Added reference to 'including the integration of a new enterprise resource planning system' in the risk factors regarding IT improvements (filed 2026-05-08)
- Added 'including tariffs and trade policies' to the risk factor on 'changes and enforcement of state and federal laws' (filed 2026-05-08)
- Added 'cybersecurity risks and cyber incidents' as a new risk factor (filed 2026-05-08)
- Updated Form 10-K reference from 'year ended December 31, 2024 filed on March 11, 2025' to 'year ended December 31, 2025 filed on February 27, 2026' (filed 2026-05-08)
- Removed:
- Removed reference to 'the Company's ability to remediate its previously disclosed material weaknesses in internal control over financial reporting' from risk factors (filed 2026-05-08)
- Removed the phrase 'growing' from 'team of field-based and traveling biomedical technicians', now reads simply 'team of field-based and traveling biomedical technicians' (filed 2026-05-08)
- Reworded:
- Changed 'the Company's ability to implement information technology improvements, including the integration of a new enterprise resource planning system, and to respond to technological changes' to separate the ERP integration as a distinct clause with more emphasis (filed 2026-05-08)
- Notes:
- The text provided is truncated at the end of both versions, limiting comparison of subsequent MD&A sections
- Comparison is limited to the provided excerpt covering forward-looking statements and overview sections
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days.
- Last 180 days4 buys ($131469) · 0 sells — 3 buying insiders
Cluster buying: 3 different insiders reported open-market purchases (SEC code P) of INFU within a 30-day window between 2026-05-08 and 2026-05-11. Disclosed Form 4 activity, not a prediction of performance or a buy signal.
Most recent open-market transaction: 2026-05-11. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about INFU's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding INFU as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 1,477,545
- Reported value $13,637,742
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 4 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
INFU had 780,802 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
INFU had 3.92% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.72 days to cover at the same settlement.
- Reported short interest (shares) 780,802
- Short interest (% of shares outstanding) 3.92%
- Prior settlement (shares) 814,607
- Reported change -4.15%
- Days to cover (reported) 5.72
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- CareCentrix
- Option Care Health
- Coram CVS/Aetna
- Aveanna Healthcare
- AccentCare
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare INFU vs…
Frequently asked questions
What does INFUSYSTEM HOLDINGS INC (INFU) do?
InfuSystem Holdings is a national healthcare service provider operating a two-platform model: Patient Services, which supplies electronic ambulatory infusion pumps and disposable supplies for outpatient oncology and other therapies administered in home and clinical settings, and Device Solutions, which offers equipment rental, sales, consumables, and biomedical support services.
What sector is INFUSYSTEM HOLDINGS INC (INFU) in?
INFUSYSTEM HOLDINGS INC (INFU) is classified in the Health Care sector. Its industry is Durable medical equipment services and home infusion therapy. It trades on NYSE American.
Who are INFUSYSTEM HOLDINGS INC's (INFU) competitors?
Notable peers of INFUSYSTEM HOLDINGS INC (INFU) include CareCentrix, Option Care Health, Coram CVS/Aetna, Aveanna Healthcare and AccentCare. This peer set is informational only — not financial advice.
Is INFUSYSTEM HOLDINGS INC (INFU) overbought or oversold right now?
INFUSYSTEM HOLDINGS INC (INFU) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 64, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on INFU come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.